When adverse effects occurred, they were typically mild and transient, with the most common being mild to moderate headaches (similar frequency to placebo groups), minor injection site reactions (redness, slight swelling), and gastrointestinal effects at higher oral doses (nausea, diarrhea)
Beyond fat loss, 5-amino-1MQ influences insulin sensitivity and glucose metabolism
Some patients walk in complaining they feel drained, others say they get dizzy when they stand up, and a few learn about it only because a routine CBC caught it before the symptoms did
On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee (PCAC) is meeting to consider whether certain peptides, including BPC-157, should be added to the 503A Bulks List, which is a list of drug substances that the FDA has approved for compounding